3.44

2.99% 0.10

Ironwood Pharmaceuticals Inc (IRWD)

Overview News Price History Option Chain Financials Discussions Forecast

Ironwood Pharmaceuticals Inc stock is traded at $3.44, with a volume of 1.75M. It is up +2.99% in the last 24 hours and down -15.69% over the past month. Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Previous Close:

$3.34

Open:

$3.33

24h Volume:

1.75M

Relative Volume:

1.11

Market Cap:

$546.81M

Revenue:

$400.57M

Net Income/Loss:

$9.21M

P/E Ratio:

-0.5695

EPS:

-6.04

Net Cash Flow:

$146.36M

1W Performance:

-18.29%

1M Performance:

-15.69%

6M Performance:

-47.00%

1Y Performance:

-63.75%

1-Day Range:

$3.26

$3.50

1-Week Range:

$3.26

$4.20

52-Week Range:

$3.26

$15.70

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name

Ironwood Pharmaceuticals Inc

Sector

Healthcare (1195)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

617-621-7722

Address

100 SUMMER STREET, SUITE 2300, BOSTON, MA

Employee

267

Twitter

@ironwoodpharma

Next Earnings Date

2024-11-07

Latest SEC Filings

IRWD's Discussions on Twitter

Compare IRWD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRWD	3.44	546.81M	400.57M	9.21M	146.36M	-6.04
ZTS	176.96	79.84B	9.15B	2.43B	2.31B	4.92
HLN	9.65	43.63B	14.26B	1.55B	0	0.3327
TAK	13.38	42.42B	30.27B	1.93B	3.45B	0.444
TEVA	17.12	19.40B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.37	15.96B	15.05B	-883.30M	1.89B	1.53

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-17-24	Initiated	Craig Hallum	Buy
Dec-14-23	Initiated	Wells Fargo	Overweight
Nov-09-23	Initiated	Jefferies	Buy
Sep-28-23	Initiated	JMP Securities	Mkt Outperform
Sep-02-22	Initiated	CapitalOne	Overweight
Apr-22-22	Initiated	Piper Sandler	Overweight
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Jun-17-20	Initiated	Northland Capital	Outperform
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Jul-23-18	Initiated	H.C. Wainwright	Sell
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform
Apr-07-17	Reiterated	Mizuho	Buy
Feb-22-17	Reiterated	Barclays	Equal Weight
Nov-04-16	Reiterated	Mizuho	Buy
Oct-24-16	Reiterated	Wedbush	Neutral
Oct-10-16	Reiterated	Mizuho	Buy
Sep-27-16	Reiterated	WallachBeth	Hold

View All

Ironwood Pharmaceuticals Inc Stock (IRWD) Latest News

04:30 AM

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by KBC Group NV - Defense World

04:30 AM

Nov 23, 2024

Principal Financial Group Inc. Has $3.03 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 23, 2024

Nov 22, 2024

Pacer Advisors Inc. Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 22, 2024

Nov 21, 2024

IRWDIronwood Pharmaceuticals, Inc.Latest Stock News & Market Updates - StockTitan

Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 - Investing.com India

Nov 21, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stake Lessened by Sumitomo Mitsui Trust Group Inc. - Defense World

Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 - Investing.com

Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 By Investing.com - Investing.com Canada

Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Stock Declines Despite Industry Gains - GuruFocus.com

Nov 20, 2024

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down - MSN

Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates - MSN

Nov 20, 2024

Nov 16, 2024

Ironwood Pharmaceuticals, Inc. Announces Resignation of Andrew Davis as Senior Vice President and Chief Business Officer, Effective November 22, 2024 - Marketscreener.com

Nov 16, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Ph - GuruFocus.com

Nov 15, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Consensus PT from Analysts - Defense World

Nov 15, 2024

Nov 14, 2024

GSA Capital Partners LLP Purchases 232,087 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire

Nov 13, 2024

Ironwood Pharmaceuticals executive resigns - Investing.com India

Nov 13, 2024

Nov 12, 2024

Ironwood Pharmaceuticals executive resigns By Investing.com - Investing.com UK

Nov 12, 2024

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results and Recent Business Performance - Defense World

Nov 12, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 12, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to “Buy” Rating by StockNews.com - Defense World

Nov 12, 2024

Creative Planning Increases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 12, 2024

Robeco Institutional Asset Management B.V. Raises Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 08, 2024